Jale Dolucan is an experienced R&D Quality Lead at Roche since September 2025, with a robust background in clinical quality and compliance gained during roles at Adaptimmune, where responsibilities included vendor quality management and oversight. Prior to that, Jale held the position of Senior Scientist at Achilles Therapeutics plc, leading immune monitoring processes and ensuring GCLP compliance. Previous roles at Spur Therapeutics focused on GCP leadership within bioanalysis, while early career experiences at the Wellcome Sanger Institute encompassed advanced research assistance and laboratory management. Jale holds an MSc in Clinical Drug Development and a BSc (Hons) in Physiology and Pharmacology, alongside continuing professional development in lab techniques.
This person is not in any teams
This person is not in any offices